An observational study in New Daily Persistent Headache (NDPH) and New Daily Persistent Headache, sponsored by The University of Texas Health Science Center, Houston. Completed at 1 site in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-02-18.
Sponsored by The University of Texas Health Science Center, Houston · Observational
Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey.
Research design: Online survey of patients with new daily persistent headache.
Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online.
Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.
145 studies on the registry are indexed under Headache Disorders; 37 are open to participants now.
This study's enrollment of 803 is above the median of 131 across 46 observational studies indexed under Headache Disorders.
Browse Headache Disorders studies →The University of Texas Health Science Center, Houston is the lead sponsor of 897 studies on the registry; 214 are open to participants now.
Of its 173 completed or terminated interventional studies of FDA-regulated products, 142 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
The population is participants with a diagnosis of NDPH. The NDPH diagnosis must come from a physician and will be further assessed with disease-specific survey questions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with NDPH will be administered an online survey.
Survey data
Time frame: At study completion, expected to be in 6-12 months.
Plan to share: Undecided
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston →